The Trial within Cohorts (TwiCs) study design in oncology: Experience and methodological reflections

11/18/2022
by   Rob Kessels, et al.
0

A Trial within Cohorts (TwiCs) study design is a trial design that uses the infrastructure of an observational cohort study to initiate a randomized trial. Upon cohort enrollment, cohort participants provided consent for being randomized in future studies without being informed. Once a new treatment is available, eligible cohort participants are randomly assigned to this new treatment or standard of care. Patients randomized to the treatment arm are offered this new treatment, which they can refuse. Patients who refuse will receive standard of care instead. Patients randomized to the standard of care arm, receive no information about the trial and continue receiving standard of care as part the cohort study. Standard cohort measures are used for outcome comparisons. The TwiCs study design aims to overcome some issues encountered in standard Randomized Controlled Trials (RCTs). An example of an issue in standard RCTs is the slow patient accrual, which a TwiCs study aims to improve by selecting patients using a cohort and only offering the intervention to patients in the active arm. In oncology, the TwiCs study design has gained increasing interest during the last decade. Despite its potential advantages over RCTs, the TwiCs study design is concerned with several methodological challenges that need careful consideration when planning a TwiCs study. In this article, we focus on these methodological challenges and reflect on them using experiences from TwiCs studies initiated in oncology. Important methodological challenges that are discussed are the timing of randomization, the issue of non-compliance (refusal) after randomization in the intervention arm, and the definition of the intention-to-treat effect in a TwiCs study and how this effect is related to its counterpart in standard RCTs.

READ FULL TEXT

page 1

page 2

page 3

page 4

research
08/19/2021

Combining Real-World and Randomized Control Trial Data Using Data-Adaptive Weighting via the On-Trial Score

Clinical trials with a hybrid control arm (a control arm constructed fro...
research
01/22/2020

Comparing the Performance of Statistical Adjustment Methods By Recovering the Experimental Benchmark from the REFLUX Trial

Much evidence in comparative effectiveness research is based on observat...
research
06/08/2022

A simple principal stratum estimator for failure to initiate treatment

A common intercurrent event affecting many trials is when some participa...
research
10/06/2022

Optimal predictive probability designs for randomized biomarker-guided oncology trials

Efforts to develop biomarker-targeted anti-cancer therapies have progres...
research
03/22/2021

A New Causal Approach to Account for Treatment Switching in Randomized Experiments under a Structural Cumulative Survival Model

Treatment switching in a randomized controlled trial is said to occur wh...
research
04/19/2023

How to design a MAMS-ROCI (aka DURATIONS) randomised trial: the REFINE-Lung case study

Background. The DURATIONS design has been recently proposed as a practic...
research
05/30/2020

Statistical Decision Properties of Imprecise Trials Assessing COVID-19 Drugs

As the COVID-19 pandemic progresses, researchers are reporting findings ...

Please sign up or login with your details

Forgot password? Click here to reset